1.
Partovi S,
Chalian M,
Fergus N,
Kosmas C,
Zipp L,
Mansoori B et al.
Magnetic resonance/positron emission tomography (MR/PET) oncologic applications: bone and soft tissue sarcoma.
Semin Roentgenol.
2014 Oct;49(4):345-52.
2.
Casali PG,
Blay JY,
Bertuzzi A,
Bielack S,
Bjerkehagen B,
Bonvalot S et al (ESMO/European Sarcoma Network Working Group).
Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis,
treatment and follow-up.
Ann Oncol.
2014 Sep;25 Suppl 3:iii102-12.
3.
Platzek I,
Beuthien-Baumann B,
Schramm G,
Maus J,
Laniado M,
Kotzerke J et al.
FDG PET/MR in initial staging of sarcoma: Initial experience and comparison with conventional imaging.
Clin Imaging.
2017 Mar - Apr;42:126-132.
4.
Jeong JH,
Cho IH,
Chun KA,
Kong EJ,
Kwon SD,
Kim JH.
Correlation Between Apparent Diffusion Coefficients and Standardized Uptake Values in Hybrid (18)F-FDG PET/MR: Preliminary Results in Rectal Cancer.
Nucl Med Mol Imaging.
2016 Jun;50(2):150-6.
5.
Atkinson W,
Catana C,
Abramson JS,
Arabasz G,
McDermott S,
Catalano O et al.
Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients.
Abdom Radiol (NY).
2016 Jul;41(7):1338-48.
6.
Schaarschmidt BM,
Grueneisen J,
Metzenmacher M,
Gomez B,
Gauler T,
Roesel C et al.
Thoracic staging with 18F-FDG PET/MR in non-small cell lung cancer - does it change therapeutic decisions in comparison to 18F-FDG PET/CT? Eur Radiol.
2017 Feb;27(2):681-688.
7.
Melsaether A,
Moy L.
Breast PET/MR Imaging.
Radiol Clin North Am.
2017 May;55(3):579-589.
8.
Schäfer JF,
Gatidis S,
Schmidt H,
Gückel B,
Bezrukov I,
Pfannenberg CA et al.
Simultaneous whole-body PET/MR imaging in comparison to PET/CT in pediatric oncology: initial results.
Radiology.
2014 Oct;273(1):220-31.